FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011309279> ?p ?o ?g. }

• W2011309279 endingPage "500" @default.
• W2011309279 startingPage "491" @default.
• W2011309279 abstract "Since the introduction of drug-eluting stents, the optimum revascularization strategy in diabetic patients with multivessel coronary disease has remained controversial. This study used multivariate logistic regression analysis and propensity score matching to compare results in 270 consecutive diabetic patients (2000-2004) with multivessel disease (≥2 vessels with a >70% de novo stenosis involving the proximal left anterior descending coronary artery) who underwent either coronary artery bypass grafting (CABG; n=142) or implantation of a drug eluting stent (DES; ie, rapamycin or paclitaxel; n=128). The following clinical outcomes (ie, major adverse cardiac or cerebrovascular events [MACCEs]) were assessed: death, nonfatal myocardial infarction (MI), stroke, and repeat revascularization at 2 years. Patients who received DESs were older (67.5 [7] years vs 65.3 [8] years; P=.05) and more often had a previous MI (49.2% vs 28.2%; P<.01), but no more often had a depressed left ventricular ejection fraction ≤45% (32.4% vs 28.1%). Coronary anatomy was more complex in surgical patients (SYNTAX score, 25.9 [7] vs 18.5 [6]; P<.001) and the quality of revascularization was better (ie, anatomically complete revascularization: 52.8% vs 28.1%; P<.01). The incidence of MACCEs was 18.7% in the CABG group and 21.8% in the DES group (adjusted odds ratio [OR] =0.93; 95% confidence interval [CI], 0.47-1.86). The composite endpoint of death, MI or stroke occurred in 15.8% undergoing CABG and 12.9% receiving a DES (adjusted OR =1.19; 95% CI, 0.72-1.88). There was less need for revascularization in CABG patients (4.3% vs 12.1%; adjusted OR=0.42; 95% CI, 0.16-1.14; P=.09). In an unselected population of diabetic patients with multivessel coronary disease, the principle advantage of CABG was the reduced need for revascularization. There was no difference in the rate of death, MI or stroke. La estrategia de revascularización en el paciente diabético con enfermedad multivaso en la era actual de los stents farmacoactivos es controvertida. Comparamos a 270 pacientes diabéticos consecutivos (2000-2004) con enfermedad multivaso (al menos 2 vasos con estenosis > 70% de novo y afección de la descendente anterior proximal) a los que se practicó cirugía de revascularización coronaria (n = 142) o se implantó stents farmacoactivos (rapamicina/paclitaxel) (n = 128) mediante análisis de regresión logística multivariable con propensity score. Analizamos los resultados clínicos (eventos cardiacos y cerebrovasculares mayores): muerte, infarto no fatal, ictus y necesidad de revascularización a 24 meses. Los pacientes que recibieron stents farmacoactivos tuvieron mayor edad (67,5 ± 7 frente a 65,3 ± 8 años; p = 0,05) y más infarto previo (el 49,2 frente al 28,2%; p < 0,01), aunque no hubo diferencias en la presencia de disfunción ventricular significativa (≤45%): el 32,4 frente al 28,1%. En los pacientes quirúrgicos, la anatomía coronaria fue más compleja: score SYNTAX (25,9 ± 7 frente a 18,5 ± 6; p < 0,001) y la calidad de la revascularización fue superior (revascularización anatómica completa, el 52,8 frente al 28,1%; p < 0,01). La incidencia total del evento combinado fue del 18,7% en el grupo quirúrgico y el 21,8% en el grupo percutáneo (odds ratio [OR] ajustada = 0,93; intervalo de confianza [IC] del 95%, 0,47-1,86). El evento combinado de muerte, infarto e ictus fue del 15,8% en el grupo quirúrgico, frente al 12,9% en el grupo de stents farmacoactivo (OR ajustada = 1,19; IC del 95%, 0,72-1,88). Los pacientes quirúrgicos tuvieron menor necesidad de revascularización (el 4,3 frente al 12,1%; OR ajustada = 0,42; IC del 95%, 0,16-1,14; p = 0,09). En una población no seleccionada de diabéticos multivaso, la ventaja de la cirugía de revascularización coronaria se centró en reducir las revascularizaciones. No encontramos diferencias en muerte, infarto o ictus." @default.
• W2011309279 created "2016-06-24" @default.
• W2011309279 creator A5012086817 @default.
• W2011309279 creator A5015560346 @default.
• W2011309279 creator A5026718444 @default.
• W2011309279 creator A5036553744 @default.
• W2011309279 creator A5049463231 @default.
• W2011309279 creator A5075785910 @default.
• W2011309279 creator A5079163932 @default.
• W2011309279 creator A5079207091 @default.
• W2011309279 creator A5089817062 @default.
• W2011309279 date "2009-05-01" @default.
• W2011309279 modified "2023-10-14" @default.
• W2011309279 title "Comparison of Medium-Term Outcomes Obtained With Drug-Eluting Stents and Coronary Artery Bypass Grafts in an Unselected Population of Diabetic Patients With Multivessel Coronary Disease. Propensity Score Analysis" @default.
• W2011309279 cites W1964365699 @default.
• W2011309279 cites W1974373682 @default.
• W2011309279 cites W1988270318 @default.
• W2011309279 cites W2010701363 @default.
• W2011309279 cites W2030116555 @default.
• W2011309279 cites W2037349293 @default.
• W2011309279 cites W2047353236 @default.
• W2011309279 cites W2053057113 @default.
• W2011309279 cites W2055767022 @default.
• W2011309279 cites W2060740613 @default.
• W2011309279 cites W2071090321 @default.
• W2011309279 cites W2083069953 @default.
• W2011309279 cites W2087150869 @default.
• W2011309279 cites W2107001549 @default.
• W2011309279 cites W2120786522 @default.
• W2011309279 cites W2120854554 @default.
• W2011309279 cites W2121690051 @default.
• W2011309279 cites W2133525542 @default.
• W2011309279 cites W2141834634 @default.
• W2011309279 cites W2143537975 @default.
• W2011309279 cites W2147673265 @default.
• W2011309279 cites W2153089743 @default.
• W2011309279 cites W2153314625 @default.
• W2011309279 cites W2156202966 @default.
• W2011309279 cites W2157647947 @default.
• W2011309279 cites W2163032264 @default.
• W2011309279 cites W2167067204 @default.
• W2011309279 cites W2170934658 @default.
• W2011309279 cites W2323060881 @default.
• W2011309279 cites W2415048463 @default.
• W2011309279 cites W3162269940 @default.
• W2011309279 doi "https://doi.org/10.1016/s1885-5857(09)71831-6" @default.
• W2011309279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19406063" @default.
• W2011309279 hasPublicationYear "2009" @default.
• W2011309279 type Work @default.
• W2011309279 sameAs 2011309279 @default.
• W2011309279 citedByCount "8" @default.
• W2011309279 countsByYear W20113092792012 @default.
• W2011309279 countsByYear W20113092792014 @default.
• W2011309279 countsByYear W20113092792015 @default.
• W2011309279 countsByYear W20113092792018 @default.
• W2011309279 countsByYear W20113092792023 @default.
• W2011309279 crossrefType "journal-article" @default.
• W2011309279 hasAuthorship W2011309279A5012086817 @default.
• W2011309279 hasAuthorship W2011309279A5015560346 @default.
• W2011309279 hasAuthorship W2011309279A5026718444 @default.
• W2011309279 hasAuthorship W2011309279A5036553744 @default.
• W2011309279 hasAuthorship W2011309279A5049463231 @default.
• W2011309279 hasAuthorship W2011309279A5075785910 @default.
• W2011309279 hasAuthorship W2011309279A5079163932 @default.
• W2011309279 hasAuthorship W2011309279A5079207091 @default.
• W2011309279 hasAuthorship W2011309279A5089817062 @default.
• W2011309279 hasConcept C126322002 @default.
• W2011309279 hasConcept C127413603 @default.
• W2011309279 hasConcept C141071460 @default.
• W2011309279 hasConcept C156957248 @default.
• W2011309279 hasConcept C164705383 @default.
• W2011309279 hasConcept C17923572 @default.
• W2011309279 hasConcept C2777546689 @default.
• W2011309279 hasConcept C2778198053 @default.
• W2011309279 hasConcept C2778213512 @default.
• W2011309279 hasConcept C2779464278 @default.
• W2011309279 hasConcept C2780400711 @default.
• W2011309279 hasConcept C2780645631 @default.
• W2011309279 hasConcept C2908647359 @default.
• W2011309279 hasConcept C500558357 @default.
• W2011309279 hasConcept C71924100 @default.
• W2011309279 hasConcept C78085059 @default.
• W2011309279 hasConcept C78519656 @default.
• W2011309279 hasConcept C99454951 @default.
• W2011309279 hasConceptScore W2011309279C126322002 @default.
• W2011309279 hasConceptScore W2011309279C127413603 @default.
• W2011309279 hasConceptScore W2011309279C141071460 @default.
• W2011309279 hasConceptScore W2011309279C156957248 @default.
• W2011309279 hasConceptScore W2011309279C164705383 @default.
• W2011309279 hasConceptScore W2011309279C17923572 @default.
• W2011309279 hasConceptScore W2011309279C2777546689 @default.
• W2011309279 hasConceptScore W2011309279C2778198053 @default.
• W2011309279 hasConceptScore W2011309279C2778213512 @default.
• W2011309279 hasConceptScore W2011309279C2779464278 @default.
• W2011309279 hasConceptScore W2011309279C2780400711 @default.
• W2011309279 hasConceptScore W2011309279C2780645631 @default.
• W2011309279 hasConceptScore W2011309279C2908647359 @default.
• W2011309279 hasConceptScore W2011309279C500558357 @default.

• next